Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
J Biol Chem ; 280(52): 42841-7, 2005 Dec 30.
Article in English | MEDLINE | ID: mdl-16115879

ABSTRACT

Adipose differentiation-related protein (ADRP) is localized to lipid droplets in most mammalian cells. ADRP, proposed to regulate fatty acid mobilization and lipid droplet formation, is linked to lipid accumulation in foam cells of human atherosclerotic lesions. In this report, we show that ADRP protein accumulates in Chinese hamster ovary fibroblastic cells cultured in the presence of oleic acid but is destabilized when fatty acid sources are removed from culture serum. The latter effect was blocked by the proteasome inhibitor MG132, whereas inhibitors of other proteolytic processes were ineffective. Pulse-chase experiments confirmed that ADRP degradation is inhibited by MG132. Conditions that stimulate ADRP degradation also promoted the covalent modification of ADRP by ubiquitin, whereas the addition of oleic acid to culture media, which promotes triacylglycerol deposition, blunted the appearance of ubiquitinated-ADRP. Treatment with MG132 increased the levels of ADRP associated with lipid droplets, as well as throughout the cytosol. Finally, we demonstrate that the disappearance of ADRP protein after the onset of perilipin expression during adipocyte differentiation is due to degradation by proteasomes Thus, proteolytic degradation of ADRP mediated through the ubiquitin/proteasome pathway appears to be a major mode for the post-translational regulation of ADRP.


Subject(s)
Membrane Proteins/biosynthesis , Proteasome Endopeptidase Complex/metabolism , Protein Processing, Post-Translational , Ubiquitin/metabolism , 3T3-L1 Cells , Adipocytes/cytology , Animals , Blotting, Northern , CHO Cells , Carrier Proteins , Cell Differentiation , Cricetinae , Culture Media/pharmacology , Cytosol/metabolism , DNA, Complementary/metabolism , Enzyme Inhibitors/pharmacology , Fatty Acids/metabolism , Fibroblasts/metabolism , Immunoblotting , Immunoprecipitation , Leupeptins/pharmacology , Lipids/chemistry , Membrane Proteins/metabolism , Mice , Microscopy, Confocal , Microscopy, Fluorescence , Oleic Acid/chemistry , Perilipin-1 , Perilipin-2 , Phosphoproteins/metabolism , Proteasome Endopeptidase Complex/chemistry , Time Factors , Transfection , Triglycerides/chemistry , Triglycerides/metabolism , Ubiquitin/chemistry
2.
Mol Pharmacol ; 62(5): 1084-93, 2002 Nov.
Article in English | MEDLINE | ID: mdl-12391271

ABSTRACT

Centrally active muscarinic agonists display pronounced analgesic effects. Identification of the specific muscarinic acetylcholine receptor (mAChR) subtype(s) mediating this activity is of considerable therapeutic interest. To examine the roles of the M(2) and M(4) receptor subtypes, the two G(i)/G(o)-coupled mAChRs, in mediating agonist-dependent antinociception, we generated a mutant mouse line deficient in both M(2) and M(4) mAChRs [M(2)/M(4) double-knockout (KO) mice]. In wild-type mice, systemic, intrathecal, or intracerebroventricular administration of centrally active muscarinic agonists resulted in robust analgesic effects, indicating that muscarinic analgesia can be mediated by both spinal and supraspinal mechanisms. Strikingly, muscarinic agonist-induced antinociception was totally abolished in M(2)/M(4) double-KO mice, independent of the route of application. The nonselective muscarinic agonist oxotremorine showed reduced analgesic potency in M(2) receptor single-KO mice, but retained full analgesic activity in M(4) receptor single-KO mice. In contrast, two novel muscarinic agonists chemically derived from epibatidine, CMI-936 and CMI-1145, displayed reduced analgesic activity in both M(2) and M(4) receptor single-KO mice, independent of the route of application. Radioligand binding studies indicated that the two CMI compounds, in contrast to oxotremorine, showed >6-fold higher affinity for M(4) than for M(2) receptors, providing a molecular basis for the observed differences in agonist activity profiles. These data provide unambiguous evidence that muscarinic analgesia is exclusively mediated by a combination of M(2) and M(4) mAChRs at both spinal and supraspinal sites. These findings should be of considerable relevance for the development of receptor subtype-selective muscarinic agonists as novel analgesic drugs.


Subject(s)
Analgesia , Muscarinic Agonists , Receptors, Muscarinic/physiology , Animals , Binding Sites , CHO Cells , Cricetinae , Injections, Intraventricular , Mice , Mice, Knockout , N-Methylscopolamine/pharmacology , Parasympatholytics/pharmacology , Receptor, Muscarinic M2 , Receptor, Muscarinic M4 , Receptors, Muscarinic/genetics , Receptors, Muscarinic/metabolism , Spinal Cord/metabolism , Tritium
3.
J Biol Chem ; 277(35): 32253-7, 2002 Aug 30.
Article in English | MEDLINE | ID: mdl-12077142

ABSTRACT

Intracellular neutral lipid storage droplets are essential organelles of eukaryotic cells, yet little is known about the proteins at their surfaces or about the amino acid sequences that target proteins to these storage droplets. The mammalian proteins Perilipin, ADRP, and TIP47 share extensive amino acid sequence similarity, suggesting a common function. However, while Perilipin and ADRP localize exclusively to neutral lipid storage droplets, an association of TIP47 with intracellular lipid droplets has been controversial. We now show that GFP-tagged TIP47 co-localizes with isolated intracellular lipid droplets. We have also detected a close juxtaposition of TIP47 with the surfaces of lipid storage droplets using antibodies that specifically recognize TIP47, further indicating that TIP47 associates with intracellular lipid storage droplets. Finally, we show that related proteins from species as diverse as Drosophila and Dictyostelium can also target mammalian or Drosophila lipid droplet surfaces in vivo. Thus, sequence and/or structural elements within this evolutionarily ancient protein family are necessary and sufficient to direct association to heterologous intracellular lipid droplet surfaces, strongly indicating that they have a common function for lipid deposition and/or mobilization.


Subject(s)
DNA-Binding Proteins/metabolism , Intracellular Signaling Peptides and Proteins , Membrane Proteins/metabolism , Phosphoproteins/metabolism , Pregnancy Proteins , Adipose Tissue/metabolism , Animals , CHO Cells , Carrier Proteins , Cricetinae , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/genetics , Dictyostelium , Drosophila , Green Fluorescent Proteins , Humans , Luminescent Proteins/genetics , Luminescent Proteins/metabolism , Mammals , Membrane Proteins/chemistry , Membrane Proteins/genetics , Mice , Perilipin-1 , Perilipin-2 , Perilipin-3 , Phosphoproteins/chemistry , Phosphoproteins/genetics , Phylogeny , Recombinant Fusion Proteins/metabolism , Sequence Homology, Amino Acid , Species Specificity , Vesicular Transport Proteins
4.
Neuron ; 33(4): 615-24, 2002 Feb 14.
Article in English | MEDLINE | ID: mdl-11856534

ABSTRACT

Oscillatory network activity at gamma frequencies is assumed to be of major importance in cortical information processing. Whereas the synaptic mechanisms of gamma oscillations have been studied in detail, the ionic currents involved at the cellular level remain to be elucidated. Here we show that in vitro gamma oscillations induced by muscarine require activation of M1 receptors on hippocampal CA3 pyramidal neurons and are absent in M1 receptor-deficient mice. M1 receptor activation depolarizes pyramidal neurons by increasing the mixed Na(+)/K(+) current I(h) and the Ca(2+)-dependent nonspecific cation current I(cat), but not by modulation of I(M). Our data provide important insight into the molecular basis of gamma oscillations by unequivocally establishing a novel role for muscarinic modulation of I(h) and I(cat) in rhythmic network activity.


Subject(s)
Biological Clocks/physiology , Cation Transport Proteins/metabolism , Hippocampus/metabolism , Ion Channels/metabolism , Nerve Net/metabolism , Pyramidal Cells/metabolism , Receptors, Muscarinic/deficiency , Animals , Biological Clocks/drug effects , Cardiovascular Agents/pharmacology , Cation Transport Proteins/drug effects , Cyclic AMP-Dependent Protein Kinases/antagonists & inhibitors , Cyclic AMP-Dependent Protein Kinases/metabolism , Hippocampus/cytology , Hippocampus/drug effects , Immunohistochemistry , Indoles/pharmacology , Interneurons/cytology , Interneurons/drug effects , Interneurons/metabolism , Ion Channels/drug effects , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Mice, Knockout , Muscarine/pharmacology , Muscarinic Agonists/pharmacology , Nerve Net/cytology , Nerve Net/drug effects , Potassium Channel Blockers/pharmacology , Pyramidal Cells/cytology , Pyramidal Cells/drug effects , Pyridines/pharmacology , Pyrimidines/pharmacology , Receptor, Muscarinic M1 , Receptors, Muscarinic/drug effects , Receptors, Muscarinic/genetics , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...